Abstract |
Golgi protein 73 (GP73) is upregulated in a variety of liver diseases, yet the detailed mechanism is poorly characterized. We analyzed GP73 in a retrospective cohort including 4211 patients with chronic liver disease (CLD) or hepatocellular carcinoma (HCC). The effect of deoxycholic acid (DCA) and nuclear factor-kappa B (NF-κB) on expression and release of GP73 in Huh-7 and SMMC7721 cells were studied. A mouse study was used to confirm our findings in vivo. A positive correlation was found between serum GP73 and total bile acid (TBA) in cirrhotic patients (r = 0.540, p < 0.001), higher than that in non-cirrhotic CLD (r = 0.318, p < 0.001) and HCC (r = 0.353, p < 0.001) patients. In Huh-7 and SMMC7721 cells, DCA upregulated the expression and release of GP73 in a dose- and time-dependent manner. After overexpressing NF-κB p65, the promoter activity, GP73 messenger RNA ( mRNA) level, and supernatant GP73 level were increased. The promotion effect of DCA on GP73 release was attenuated after inhibiting the NF-κB pathway. Mutating the binding sites of NF-κB in the sequence of the GP73 promoter led to a declined promoting effect of DCA on GP73. The upregulation role of DCA in GP73 expression through the NF-κB pathway was confirmed in vivo. In addition, exposure to DCA caused disassembly of Golgi apparatus. In summary, DCA upregulates the expression and release of GP73 via activating the NF-κB pathway and destroying the Golgi structure.
|
Authors | Danli Yang, Mingjie Yao, Ying Yan, Yanna Liu, Xiajie Wen, Xiangmei Chen, Fengmin Lu |
Journal | Biomolecules
(Biomolecules)
Vol. 11
Issue 2
(02 02 2021)
ISSN: 2218-273X [Electronic] Switzerland |
PMID | 33540642
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Bile Acids and Salts
- GOLM1 protein, human
- GP73 protein, mouse
- Membrane Proteins
- NF-kappa B p50 Subunit
- NFKB1 protein, human
- Phosphoproteins
- Deoxycholic Acid
- Nfkb1 protein, mouse
|
Topics |
- Adult
- Animals
- Bile Acids and Salts
(metabolism)
- Carcinoma, Hepatocellular
(drug therapy, metabolism)
- Cell Line, Tumor
- Chronic Disease
- Deoxycholic Acid
(metabolism, pharmacology)
- Female
- Fibrosis
- Gene Expression Profiling
- Humans
- Liver Cirrhosis
(drug therapy, metabolism)
- Liver Diseases
(drug therapy, metabolism)
- Liver Neoplasms
(drug therapy, metabolism)
- Male
- Membrane Proteins
(biosynthesis)
- Mice
- Mice, Inbred C57BL
- Microscopy, Fluorescence
- Middle Aged
- NF-kappa B p50 Subunit
(biosynthesis)
- Phosphoproteins
(biosynthesis)
- Retrospective Studies
- Up-Regulation
|